Warby Parker Inc

Warby Parker Inc (WRBY) Stock Analysis

$23.340

-1.186 (-5.08%)At close

Loading chart…
High
25.110
Open
24.610
VWAP
23.93
Volume
2.79M
Mkt Cap
1.93B
Low
23.330
Amount
66.68M
EV/EBITDA, TTM
242.16

Warby Parker Inc. is a lifestyle brand that operates at the intersection of design, technology, healthcare, and social enterprise. The Company provides vision care by offering eyewear, contacts, and eye care directly to consumers through its integrated, omnichannel platform. It operates an integrated omnichannel platform across digital commerce and approximately 323 retail stores. It enables customers to customize lenses with a variety of options, including single-vision, progressive, light-responsive, polarized, blue-light-filtering, tinted, and non-prescription lenses. It also offers lens replacements, allowing customers to keep frames as prescription changes. It offers a selection of contact lenses from third-party manufacturers. It also offers in-person eye exams utilizing technology, including digital retinal imaging. It provides telehealth services, such as its Virtual Vision Test app, which enables customers to renew prescriptions.

AI analysis of Warby Parker Inc (WRBY)

Hold

Warby Parker Inc is currently a hold. The stock is priced at $25.3, which is near the lower Fibonacci support level of $24.665. The RSI is at 43.293, suggesting it is nearing oversold territory, but not yet a strong buy signal. Additionally, the forward P/E ratio stands at 54.35, indicating high valuation concerns relative to earnings potential. While analysts forecast an 11% revenue growth for 2026 and 17% for 2027, the recent insider selling by Co-CEO David Gilboa, who sold shares to meet tax obligations, raises some caution. The main risk is the recent 5-day price decline of 6.40%, which could indicate short-term weakness in market sentiment.

Valuation Metrics

The current forward P/E ratio for Warby Parker Inc (WRBY) is 54.35, compared to its 5-year average forward P/E of 96.74.

Forward P/E

Fair
5Y Average P/E
96.74
Current P/E
54.35
Overvalued
366.25
Undervalued
-172.77

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
-37.49
Current EV/EBITDA
242.16
Overvalued
569.80
Undervalued
-644.78

Forward P/S

Fair
5Y Average P/S
3.04
Current P/S
2.71
Overvalued
4.68
Undervalued
1.40

Alphio AI Price Scenarios for WRBY

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%WRBY

$20.56

Scenario price

B

Base

Base · 50%WRBY

$20.20

Scenario price

B

Bear

Bear · 25%WRBY

$16.74

Scenario price

Whales holding WRBY

B

Bluespring Wealth Management, LLC

+ HoldingWRBY

+1.33%

3M Return

V

Vaughan Nelson Investment Management, L.P.

+ HoldingWRBY

+1.31%

3M Return

J

J. Goldman & Co., L.P.

+ HoldingWRBY

+1.09%

3M Return

G

Gardner Russo & Quinn LLC

+ HoldingWRBY

+0.27%

3M Return

D

Durable Capital Partners, LP

+ HoldingWRBY

-5.68%

3M Return

D

Discovery Capital Management, LLC

+ HoldingWRBY

-9.41%

3M Return

Events Timeline

2026-08-06 (ET)

09:00:00

Western Digital and SanDisk Shares Plunge as Market Awaits Employment Data

2026-05-20 (ET)

10:10:00

Warby Parker Shares Drop 7.5% to $23.59

2026-05-19 (ET)

16:30:00

Major Averages Decline for Second Day, Tech Stocks Lead Losses

14:40:00

Google Partners with Gentle Monster and Samsung to Launch First Audio Glasses

14:20:00

Shares Down 9% to $25.99

News

WRBY FAQ — answered by Alphio AI

Warby Parker Inc. is a lifestyle brand that operates at the intersection of design, technology, healthcare, and social enterprise. The Company provides vision care by offering eyewear, contacts, and eye care directly to consumers through its integrated, omnichannel platform. It operates an integrated omnichannel platform across digital commerce and approximately 323 retail stores. It enables customers to customize lenses with a variety of options, including single-vision, progressive, light-responsive, polarized, blue-light-filtering, tinted, and non-prescription lenses. It also offers lens replacements, allowing customers to keep frames as prescription changes. It offers a selection of contact lenses from third-party manufacturers. It also offers in-person eye exams utilizing technology, including digital retinal imaging. It provides telehealth services, such as its Virtual Vision Test app, which enables customers to renew prescriptions. It operates in the Consumer Cyclicals sector (OPHTHALMIC GOODS industry).

Warby Parker Inc is currently a hold. The stock is priced at $25.3, which is near the lower Fibonacci support level of $24.665. The RSI is at 43.293, suggesting it is nearing oversold territory, but not yet a strong buy signal. Additionally, the forward P/E ratio stands at 54.35, indicating high valuation concerns relative to earnings potential. While analysts forecast an 11% revenue growth for 2026 and 17% for 2027, the recent insider selling by Co-CEO David Gilboa, who sold shares to meet tax obligations, raises some caution. The main risk is the recent 5-day price decline of 6.40%, which could indicate short-term weakness in market sentiment.

Community

More ↗
0xSkewfalcon9/27/2026

On Friday, over $253K was spent on $WRBY $30 calls expiring December 18th. Warby Parker closed at $26.71 on Friday, implying about 12.3% upside over the next three months or so.

Show more
Sign up or log in to join the discussion

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading